Oragenics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Oragenics and other ETFs, options, and stocks.About OGEN
Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains.
CEOJanet Huffman
CEOJanet Huffman
Employees3
Employees3
HeadquartersSarasota, Florida
HeadquartersSarasota, Florida
Founded1996
Founded1996
Employees3
Employees3
OGEN Key Statistics
Market cap4.69M
Market cap4.69M
Price-Earnings ratio-0.07
Price-Earnings ratio-0.07
Dividend yield—
Dividend yield—
Average volume36.13K
Average volume36.13K
High today$1.15
High today$1.15
Low today$1.09
Low today$1.09
Open price$1.09
Open price$1.09
Volume16.27K
Volume16.27K
52 Week high$18.90
52 Week high$18.90
52 Week low$1.01
52 Week low$1.01
Stock Snapshot
The current Oragenics(OGEN) stock price is $1.14, with a market capitalization of 4.69M. The stock trades at a price-to-earnings (P/E) ratio of -0.07.
On 2025-11-15, Oragenics(OGEN) stock traded between a low of $1.09 and a high of $1.15. Shares are currently priced at $1.14, which is +4.1% above the low and -1.3% below the high.
Oragenics(OGEN) shares are trading with a volume of 16.27K, against a daily average of 36.13K.
During the past year, Oragenics(OGEN) stock moved between $1.01 at its lowest and $18.90 at its peak.
During the past year, Oragenics(OGEN) stock moved between $1.01 at its lowest and $18.90 at its peak.
People also own
Based on the portfolios of people who own OGEN. This list is generated using Robinhood data, and it’s not a recommendation.